Macrophage-Biomimetic Nanoparticles Ameliorate Ulcerative Colitis through Reducing Inflammatory Factors Expression

BACKGROUND AND AIMS: Inflammatory mediator S100A9 is dramatically elevated in ulcerative colitis and correlates with disease severity. S100A9 is a potential molecule to target for the treatment of colitis, but to date, there is no effective targeting method. The aim of this study was to develop a sa...

Descripción completa

Detalles Bibliográficos
Autores principales: Li, Zhengshuo, Zhang, Xiaoyue, Liu, Can, Peng, Qiu, Wu, Yangge, Wen, Yuqing, Zheng, Run, Yan, Qun, Ma, Jian
Formato: Online Artículo Texto
Lenguaje:English
Publicado: S. Karger AG 2021
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9274947/
https://www.ncbi.nlm.nih.gov/pubmed/34724662
http://dx.doi.org/10.1159/000519363

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9274947/
https://www.ncbi.nlm.nih.gov/pubmed/34724662
http://dx.doi.org/10.1159/000519363

Ejemplares similares